Linden Advisors’s Social Leverage Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 SLACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-77,454
Closed -$85K 690
2021
Q2
$85K Buy
+77,454
New +$78.7K ﹤0.01% 779

Other funds holding SLACW

Linden Advisors's SLACW Position: Q3 2021 in Review

Linden Advisors sold out of Social Leverage Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 (SLACW) in Q3 2021, closing a stake of 77,454 shares — an estimated $85K sold.

Linden Advisors first reported a position in SLACW in Q2 2021 and held it in 1 quarter. The position peaked at $85K in Q2 2021. 44 funds tracked by Wall St. Rank hold SLACW as of Q3 2021.

  • Linden Advisors reported no remaining Social Leverage Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position as of Q3 2021 after selling out during the quarter.
  • Linden Advisors sold 77,454 Social Leverage Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 shares in Q3 2021, an estimated $85K.
  • Linden Advisors first reported a position in Social Leverage Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 in Q2 2021 and held it in 1 quarter.
  • Linden Advisors's Social Leverage Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position peaked at $85K in Q2 2021.
  • 44 funds tracked by Wall St. Rank held Social Leverage Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 as of Q3 2021.

Based on Linden Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.